As large biopharma companies have increasingly turned to China for novel biotech innovation, political calls in the U.S. to ...

Biotech is increasingly financed, governed and regulated as though it were a mature pharmaceutical industry rather than a ...

The United States's dominance in biotech innovation is crucial to our national interests and global security. In recent years, China has quickly become a powerhouse, bolstered by its biotech-friendly ...

A mgen plans to invest more than $600 million in a new, state-of-the-art center for science and innovation at its global headquarters in Thousand Oaks, California. The center is designed to bring ...

Biotech companies have always licensed programs, but never so many from one region in particular.

AI‑assisted tools are rapidly transforming biotech innovation, enabling faster discovery and more sophisticated experimentation. At the same time, increased reliance on these tools raises complex and ...

HanchorBio, Inc. (TPEx: 7827), a global clinical-stage biotechnology company advancing next-generation immunotherapies for oncology and autoimmune diseases, today announced that it will be officially ...

Boston remains biotech's most influential hub, but the questions facing the region are increasingly global. | Senior Writer Darren Incorvaia talks with industry leaders and experts from Flagship ...

A UK biotechnology company developing sustainable natural rubber from specially engineered dandelions has secured £3.4m in ...

China and the U.S. are in a race for preeminence in biotechnology. The U.S. is still dominant in biology and life sciences research, but China is catching up fast. At the same time, Congress and the ...

In the fast-paced world of biotechnology, success hinges on more than groundbreaking science—it requires the right connections, strategic partnerships, and access to capital. Biotech Showcase delivers ...

Michael Schultz is director of venture operations at Portal Innovations, where he is always looking for innovations that could revolutionize the life sciences. "We work with many startups, and all of ...